Search Results - "Lorscheider, J."

Influence of age at disease onset on future relapses and disability progression in patients with multiple sclerosis on immunomodulatory treatment by Wyl, V., Décard, B. F., Benkert, P., Lorscheider, J., Hänni, P., Lienert, C., Kuhle, J., Derfuss, T., Kappos, L., Yaldizli, Ö.

“…Background and purpose To investigate the relation of age at disease onset and clinical outcomes across the lifespan from adolescence in patients with multiple…”
Get full text

Accurate classification of secondary progression in multiple sclerosis using a decision tree by Ramanujam, Ryan, Zhu, Feng, Fink, Katharina, Karrenbauer, Virginija Danylaitė, Lorscheider, Johannes, Benkert, Pascal, Kingwell, Elaine, Tremlett, Helen, Hillert, Jan, Manouchehrinia, Ali

“…Background: The absence of reliable imaging or biological markers of phenotype transition in multiple sclerosis (MS) makes assignment of current phenotype…”
Get full text

Anti‐inflammatory disease‐modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study by Lorscheider, J., Kuhle, J., Izquierdo, G., Lugaresi, A., Havrdova, E., Horakova, D., Hupperts, R., Duquette, P., Girard, M., Prat, A., Grand'Maison, F., Grammond, P., Sola, P., Ferraro, D., Trojano, M., Ramo‐Tello, C., Lechner‐Scott, J., Pucci, E., Solaro, C., Slee, M., Van Pesch, V., Sanchez Menoyo, J. L., Walt, A., Butzkueven, H., Kappos, L., Kalincik, T.

“…Background and purpose Treatment options in primary progressive multiple sclerosis (PPMS) are scarce and, with the exception of ocrelizumab, anti‐inflammatory…”
Get full text

Anti‐inflammatory disease‐modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study

Get full text

Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study by Benkert, Pascal, Meier, Stephanie, Schaedelin, Sabine, Manouchehrinia, Ali, Yaldizli, Özgür, Maceski, Aleksandra, Oechtering, Johanna, Achtnichts, Lutz, Conen, David, Derfuss, Tobias, Lalive, Patrice H, Mueller, Christian, Müller, Stefanie, Naegelin, Yvonne, Oksenberg, Jorge R, Pot, Caroline, Salmen, Anke, Willemse, Eline, Kockum, Ingrid, Blennow, Kaj, Zetterberg, Henrik, Gobbi, Claudio, Kappos, Ludwig, Wiendl, Heinz, Berger, Klaus, Sormani, Maria Pia, Granziera, Cristina, Piehl, Fredrik, Leppert, David, Kuhle, Jens, Aeschbacher, Stefanie, Barakovic, Muhamed, Buser, Andreas, Chan, Andrew, Disanto, Giulio, D'Souza, Marcus, Du Pasquier, Renaud, Findling, Oliver, Galbusera, Riccardo, Hrusovsky, Kevin, Khalil, Michael, Lorscheider, Johannes, Mathias, Amandine, Orleth, Annette, Radue, Ernst-Wilhelm, Rahmanzadeh, Reza, Sinnecker, Tim, Subramaniam, Suvitha, Vehoff, Jochen, Wellmann, Sven, Wuerfel, Jens, Zecca, Chiara

“…Serum neurofilament light chain (sNfL) is a biomarker of neuronal damage that is used not only to monitor disease activity and response to drugs and to…”
Get full text

Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis by Meier, Stephanie, Willemse, Eline A J, Schaedelin, Sabine, Oechtering, Johanna, Lorscheider, Johannes, Melie-Garcia, Lester, Cagol, Alessandro, Barakovic, Muhamed, Galbusera, Riccardo, Subramaniam, Suvitha, Barro, Christian, Abdelhak, Ahmed, Thebault, Simon, Achtnichts, Lutz, Lalive, Patrice, Müller, Stefanie, Pot, Caroline, Salmen, Anke, Disanto, Giulio, Zecca, Chiara, D'Souza, Marcus, Orleth, Annette, Khalil, Michael, Buchmann, Arabella, Du Pasquier, Renaud, Yaldizli, Özgür, Derfuss, Tobias, Berger, Klaus, Hermesdorf, Marco, Wiendl, Heinz, Piehl, Fredrik, Battaglini, Marco, Fischer, Urs, Kappos, Ludwig, Gobbi, Claudio, Granziera, Cristina, Bridel, Claire, Leppert, David, Maleska Maceski, Aleksandra, Benkert, Pascal, Kuhle, Jens

“…There is a lack of validated biomarkers for disability progression independent of relapse activity (PIRA) in multiple sclerosis (MS). To determine how serum…”
Get more information

Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data network by Signori, Alessio, Lorscheider, Johannes, Vukusic, Sandra, Trojano, Maria, Iaffaldano, Pietro, Hillert, Jan, Hyde, Robert, Pellegrini, Fabio, Magyari, Melinda, Koch-Henriksen, Nils, Sørensen, Per Soelberg, Spelman, Tim, van der Walt, Anneke, Horakova, Dana, Havrdova, Eva, Girard, Marc, Eichau, Sara, Grand'Maison, Francois, Gerlach, Oliver, Terzi, Murat, Ozakbas, Serkan, Skibina, Olga, Van Pesch, Vincent, Sa, Maria Jose, Prevost, Julie, Alroughani, Raed, McCombe, Pamela A, Gouider, Riadh, Mrabet, Saloua, Castillo-Trivino, Tamara, Zhu, Chao, de Gans, Koen, Sánchez-Menoyo, José Luis, Yamout, Bassem, Khoury, Samia, Sormani, Maria Pia, Kalincik, Tomas, Butzkueven, Helmut

“…BackgroundOver the decades, several natural history studies on patients with primary (PPMS) or secondary progressive multiple sclerosis (SPMS) were reported…”
Get full text

Recanalization Therapies for Large Vessel Occlusion Due to Cervical Artery Dissection: A Cohort Study of the EVA-TRISP Collaboration by Traenka, Christopher, Lorscheider, Johannes, Hametner, Christian, Baumgartner, Philipp, Gralla, Jan, Magoni, Mauro, Martinez-Majander, Nicolas, Casolla, Barbara, Feil, Katharina, Pascarella, Rosario, Papanagiotou, Panagiotis, Nordanstig, Annika, Padjen, Visnja, Cereda, Carlo W, Psychogios, Marios, Nolte, Christian H, Zini, Andrea, Michel, Patrik, Béjot, Yannick, Kastrup, Andreas, Zedde, Marialuisa, Kägi, Georg, Kellert, Lars, Henon, Hilde, Curtze, Sami, Pezzini, Alessandro, Arnold, Marcel, Wegener, Susanne, Ringleb, Peter, Tatlisumak, Turgut, Nederkoorn, Paul J, Engelter, Stefan T, Gensicke, Henrik

“…This study aimed to investigate the effect of endovascular treatment (EVT, with or without intravenous thrombolysis [IVT]) versus IVT alone on outcomes in…”
Get full text

Disease modifying treatment ameliorates disability worsening in patients with aggressive PPMS: results from the Big MS Data network by Lorscheider, J, Signori, A, Subramaniam, S, Vukusic, S, Trojano, M, Iaffaldano, P, Hillert, J, Hyde, R, Pellegrini, F, Magyari, M, Sorensen, PS, Spelman, T, Van der Walt, A, Kalincik, T, Gray, O, Horakova, D, Butzkueven, H

Get full text

Heterogeneity on long-term disability trajectories in secondary progressive MS patients - a latent class analysis from big MS data network by Signori, A, Lorscheider, J, Vukusic, S, Trojano, M, Iaffaldano, P, Hillert, J, Hyde, R, Pellegrini, F, Magyari, M, Sorensen, PS, Spelman, T, Van der Walt, A, Sormani, MP, Kalincik, T, Gray, O, Horakova, D, Butzkueven, H

Get full text

Increased serum glial fibrillary acidic protein (GFAP) levels predict disease progression in B cell depleted patients with progressive MS by Benkert, P, Maceski, A, Lorscheider, J, Schaedelin, S, Willemse, EAJ, Meier, S, Gress, U, Melie-Garcia, L, Cagol, A, Galbusera, R, Subramaniam, S, Barakovic, M, Achtnichts, L, Lalive, P, Mueller, S, Pot, C, Salmen, A, Disanto, G, Zecca, C, Orleth, A, Yaldizli, O, Derfuss, T, Oechtering, J, Piehl, F, Kappos, L, Gobbi, C, Granziera, C, Leppert, D, Bridel, C, Kuhle, J

Get full text

Personalized treatment decision algorithms for the clinical implementation of serum neurofilament light chain in multiple sclerosis: a modified Delphi study by Janiaud, P, Benkert, P, Achtnichts, L, Bar-Or, A, Lang, VB, Bridel, C, Comabella, M, Disanto, G, Findling, O, Gobbi, C, Granziera, C, Herwerth, M, Hoepner, R, Horakova, D, Kamber, N, Khalil, M, Kunz, P, Lalive, P, Linker, R, Lorscheider, J, Muller, S, Oechtering, J, Pettypool, V, Piehl, F, Pot, C, Roth, P, Theaudin, M, Tintore, M, Tur, C, Uffer, D, Vehoff, J, Wiendl, H, Ziemssen, T, Zecca, C, Salmen, A, Leppert, D, Derfuss, T, Kappos, L, Kuhle, J, Hemkens, L, Yaldizli, O

Get full text

Serum glial fibrillary acidic protein (GFAP) is a longitudinal indicator of disease progression in MS while neurofilament light chain (NfL) associates with therapy response in patients under B-cell depleting therapy by Benkert, P, Maceski, AM, Schadelin, S, Willemse, E, Meier, S, Melie-Garcia, L, Cagol, A, Galbusera, R, Subramaniam, S, Lorscheider, J, Fischer-Barnicol, B, Achtnichts, L, Findling, O, Lalive, P, Bridel, C, Muller, S, Pot, C, Mathias, A, Du Pasquier, R, Salmen, A, Hoepner, R, Chan, A, Disanto, G, Zecca, C, Orleth, A, DSouza, M, Yaldizli, O, Derfuss, T, Oechtering, J, Gobbi, C, Khalil, M, Abdelhak, A, Oksenberg, JR, Hermesdorf, M, Berger, K, Wiendl, H, Piehl, F, Conen, D, Buser, A, Kappos, L, Granziera, C, Leppert, D, Kuhle, J

Get full text